Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Schizophrenia and other psychoses.in: Tasman A. Kay J. Lieberman J.A. Psychiatry. 2nd ed. John Wiley & Sons, Ltd., Chichester, UK2003: 1131-1206
- Glutathione: a novel treatment target in psychiatry.Trends Pharmacol Sci. 2008; 29: 346-351
- N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial.Biol Psychiatry. 2008; 64: 361-368
- Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.Eur J Neurosci. 2000; 12: 3721-3728
- N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.Biol Psychiatry. 2012; 71: 1006-1014
- Regulation of glutathione synthesis.Mol Aspects Med. 2009; 30: 42-59
- Glutathione and Parkinson's disease: is this the elephant in the room?.Biomed Pharmacother. 2008; 62: 236-249
- Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia.World J Biol Psychiatry. 2009; 10: 626-628
- N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.J Affect Disord. 2011; 129: 317-320
- N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.Neurosci Lett. 2011; 499: 149-153